Bringing new medical devices to patients is often challenging, especially when they involve complex drug delivery. Companies often struggle to turn their ideas into working devices and produce them consistently in large numbers while keeping quality high and patients safe. This case study shows how TekCyte helps solve these common industry problems.
Our partnership with Alyra Biotech is an excellent example of our involvement in this work. Here, we successfully helped develop and manufacture their critical medical device, enabling Alyra Biotech to bring its product to the clinic and accelerate its path to market.
Alyra Biotech
Alyra Biotech is a pioneering company dedicated to advancing therapeutic solutions to improving the management of pain and wellbeing in women. They approached TekCyte with a visionary concept for a medical device that required a precise drug release profile.
Alyra Biotech sought a partner with robust research and development capabilities to transform this product concept into a tangible, effective product and quality manufacturing capabilities for human clinical use.
The Dual Challenge: Precision & Scalability
Alyra Biotech had two main challenges to solve to make their new medical device a reality. First, they needed to design the device to release the drug exactly as required while also fitting all the required physical specifications. This meant balancing complicated drug science with practical engineering.
Second, they faced the challenge of manufacturing the device on a large scale. They needed a manual production process that could reliably create many devices of the same high quality, with patient safety in mind. Ensuring every single device was identical was crucial for using them in clinical trials.
TekCyte’s Integrated Solution
TekCyte leveraged its strong R&D skills to help Alyra Biotech achieve its initial goal. Our team carefully tested different ways to formulate drug-release compounds. TekCyte worked closely with Alyra Biotech to refine the delivery method of the drug until it achieved the exact release profile required. This teamwork successfully turned Alyra Biotech’s complex idea into a working and effective solution.
After this, we applied our expertise in designing the manufacturing tools required to meet the exacting dimensions of the final medical device.
Driving Future Success
Thanks to this successful teamwork, TekCyte manufactured the medical device that Alyra Biotech required for its very important first Phase I clinical trial. The device worked exceptionally well, and the trial was expanded to a second Phase I trial, including even more patients.
We continue to be an essential partner for Alyra Biotech’s medical device for this larger clinical trial phase. Supporting Alyra Biotech’s growth and helping them bring new innovative treatments to patients.
